By Brazil Stock Guide – Ecopetrol’s bid to take control of Brava Energia (B3: BRAV3) has hit a regulatory roadblock in Brazil, after the country’s securities watchdog demanded changes to the tender offer documents. Ecopetrol Investimentos do Brasil, a wholly owned unit of Ecopetrol (NYSE: EC), will appeal the decision to the CVM board. Until then, the offer is suspended.
Brava said it received notice on June 15, 2026, that Ecopetrol’s Brazilian unit had been informed by the CVM of required changes to the offer notice. The offeror “respectfully disagrees” with the determinations made by the CVM’s technical staff, Ecopetrol said in a letter sent to Brava.
The dispute shifts the center of the transaction from price to process. Investors had been watching the economics of the bid, the level of shareholder acceptance and Ecopetrol’s appetite for Brazilian oil and gas assets. Now, the key question is whether the regulator will allow the offer to proceed as designed or force the company to rewrite parts of the deal.
The Deal Is Still Alive
The suspension does not kill the transaction. Ecopetrol said it will file its appeal as quickly as possible and use its best efforts to resume the offer. The company also said it remains confident that the tender offer will ultimately be allowed to proceed as originally proposed.
Still, the filing leaves a critical gap for the market. Brava did not disclose which parts of the offer notice the CVM wants changed. That matters because the impact can vary widely. A procedural change may only delay the calendar. A structural change could alter the risk-reward for shareholders.
For now, the transaction has moved into a regulatory holding pattern. The CVM board will decide whether the technical staff’s objections stand. Until that ruling comes, Ecopetrol cannot restart the offer.
Arbitrage Moves to Wait Mode
The immediate losers are investors betting on a clean takeover timetable. Merger arbitrage funds and minority shareholders now face a less predictable sequence of events. The offer still exists, but the date and terms of its return are no longer clear.
The CVM, meanwhile, has put shareholder protection at the center of the process. A tender offer for control must give investors clarity on price, deadlines, rights and acceptance rules. Any ambiguity can influence participation and affect the treatment of minority holders.
For Brava, the statement keeps the company in a neutral position. It informed the market and said it would disclose any further material developments. For Ecopetrol, the appeal becomes a test of execution. The Colombian company must persuade the regulator without letting momentum drain from the transaction.
The next catalyst is now clear: a decision from the CVM board. Until then, Ecopetrol’s bid for Brava remains alive, but frozen.